PT731710E - Composicoes contendo timosine alpha 1 destinadas ao tratamento de pacientes sofrendo duma doenca de figado descompensado - Google Patents

Composicoes contendo timosine alpha 1 destinadas ao tratamento de pacientes sofrendo duma doenca de figado descompensado

Info

Publication number
PT731710E
PT731710E PT94901265T PT94901265T PT731710E PT 731710 E PT731710 E PT 731710E PT 94901265 T PT94901265 T PT 94901265T PT 94901265 T PT94901265 T PT 94901265T PT 731710 E PT731710 E PT 731710E
Authority
PT
Portugal
Prior art keywords
timosine
disordered
alpha
disease
treatment
Prior art date
Application number
PT94901265T
Other languages
English (en)
Inventor
Paul B Chretien
Milton G Mutchnick
Original Assignee
Sciclone Pharmaceuticals Inc
Univ Wayne State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sciclone Pharmaceuticals Inc, Univ Wayne State filed Critical Sciclone Pharmaceuticals Inc
Priority claimed from PCT/US1993/010619 external-priority patent/WO1995012405A1/en
Publication of PT731710E publication Critical patent/PT731710E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PT94901265T 1993-11-05 1993-11-05 Composicoes contendo timosine alpha 1 destinadas ao tratamento de pacientes sofrendo duma doenca de figado descompensado PT731710E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1993/010619 WO1995012405A1 (en) 1993-11-05 1993-11-05 Method and composition for treatment of patients having decompensated liver disease

Publications (1)

Publication Number Publication Date
PT731710E true PT731710E (pt) 2003-09-30

Family

ID=22237139

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94901265T PT731710E (pt) 1993-11-05 1993-11-05 Composicoes contendo timosine alpha 1 destinadas ao tratamento de pacientes sofrendo duma doenca de figado descompensado

Country Status (11)

Country Link
EP (1) EP0731710B1 (pt)
KR (1) KR100298859B1 (pt)
CA (1) CA2175337C (pt)
DE (1) DE69332982T2 (pt)
DK (1) DK0731710T3 (pt)
ES (1) ES2194860T3 (pt)
HK (1) HK1021685A1 (pt)
MX (1) MXPA94003453A (pt)
MY (1) MY111342A (pt)
NO (1) NO961775D0 (pt)
PT (1) PT731710E (pt)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW224053B (pt) * 1991-09-13 1994-05-21 Paul B Chretien
EP0728010A4 (en) * 1992-02-06 1997-10-01 Sciclone Pharmaceuticals METHOD FOR TREATING HEPATITIS B CARRIERS WITH A MINOR DISEASE
WO1994001125A1 (en) * 1992-07-13 1994-01-20 Sherman Kenneth E Composition and method of treating hepatitis b

Also Published As

Publication number Publication date
CA2175337C (en) 2000-06-20
KR100298859B1 (ko) 2001-10-22
EP0731710B1 (en) 2003-05-14
DK0731710T3 (da) 2003-06-16
DE69332982T2 (de) 2004-09-09
MXPA94003453A (es) 2004-08-16
HK1021685A1 (en) 2000-06-23
NO961775L (no) 1996-05-02
MY111342A (en) 1999-11-30
ES2194860T3 (es) 2003-12-01
NO961775D0 (no) 1996-05-02
EP0731710A1 (en) 1996-09-18
CA2175337A1 (en) 1995-05-11
DE69332982D1 (de) 2003-06-18
EP0731710A4 (en) 1999-12-22
KR960706352A (ko) 1996-12-09

Similar Documents

Publication Publication Date Title
HUP9903906A3 (en) Use of chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
EP0740937A3 (fr) Utilisation de rétinoides pour la fabrication d'une composition cosmétique ou pharmaceutique
EP0735870A4 (en) USE OF PHOSPHOLIPASE-A2 INHIBITORS FOR TREATING ALZHEIMER'S DISEASE
AU4048295A (en) Peptide medicaments for the treatment of disease
FI953915A (fi) Dupuytrenin taudin lievittämiseen
EP0331620A3 (en) Agent for the treatment of parkinson's disease
AU1197992A (en) The use of loperamide and related compounds for treatment of respiratory disease symptoms
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
ZA944238B (en) New use of old drugs
IL125775A0 (en) Use of a zwitterion composition and a pharmaceutical composition containing the same
FI962685A0 (fi) 2,3-diaryyli-1-bentsopyraanijohdannaisten käyttö lääkkeen valmistamiseksi luukadon ja osteoporoosin hoitamiseksi ja estämiseksi
FR2678170B1 (fr) Compositions orales pour la prevention d'odontonecrose et de maladie paradentaire.
IL117695A0 (en) Pharmaceutical agents for the treatment of alzheimer's disease
HUP9901303A3 (en) A pharmaceutical composition for the treatment of autoimmune diseases
FR2714603B1 (fr) Composition dermatologique et son utilisation pour la préparation d'un médicament.
PT731710E (pt) Composicoes contendo timosine alpha 1 destinadas ao tratamento de pacientes sofrendo duma doenca de figado descompensado
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
EP0755262A4 (en) PNEUMOPATHY TREATMENT COMPOSITION
HUP0000570A3 (en) Use of 17 alpha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
IL107515A0 (en) Diagnosis of mental disorders
AU1455395A (en) Use of m3 muscarinic antagonists for the treatment of motion sickness
HUP0000476A3 (en) Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
HU9600725D0 (en) Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease
ITMI930453A1 (it) Composizione farmaceutica avente attivita' antiasmatica
SI0858337T1 (sl) Farmacevtski sestavek za zdravljenje avtoimunskihbolezni